Experimental vaccine protects against C. diff disease and recurrence

A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine administered to the mucosal lining of the colon…

Continue Reading

News Source: medicalxpress.com